Compare CTRA & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTRA | BAX |
|---|---|---|
| Founded | 1989 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1B | 9.4B |
| IPO Year | 1990 | N/A |
| Metric | CTRA | BAX |
|---|---|---|
| Price | $26.44 | $19.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 10 |
| Target Price | ★ $32.81 | $25.67 |
| AVG Volume (30 Days) | 6.2M | ★ 7.9M |
| Earning Date | 11-03-2025 | 10-30-2025 |
| Dividend Yield | ★ 3.35% | 0.21% |
| EPS Growth | ★ 31.20 | N/A |
| EPS | ★ 2.17 | N/A |
| Revenue | $6,666,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $47.52 | $5.20 |
| Revenue Next Year | $5.65 | $2.02 |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | ★ 25.92 | 3.90 |
| 52 Week Low | $22.33 | $17.40 |
| 52 Week High | $29.95 | $37.74 |
| Indicator | CTRA | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 52.32 |
| Support Level | $26.27 | $17.92 |
| Resistance Level | $27.11 | $19.17 |
| Average True Range (ATR) | 0.57 | 0.44 |
| MACD | -0.11 | 0.18 |
| Stochastic Oscillator | 33.00 | 85.56 |
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.